Published in Antimicrob Agents Chemother on November 01, 1978
Three decades of beta-lactamase inhibitors. Clin Microbiol Rev (2010) 5.54
Purification and properties of a new beta-lactamase from Pseudomonas cepacia. Antimicrob Agents Chemother (1980) 4.09
Comparative inhibition beta-lactamases by novel beta-lactam compounds. Antimicrob Agents Chemother (1979) 2.97
Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Antimicrob Agents Chemother (1980) 2.53
Antibiotic combinations: should they be tested? Clin Microbiol Rev (1988) 2.34
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J (1982) 1.74
Inactivation of beta-lactam antibiotics by Legionella pneumophila. Antimicrob Agents Chemother (1979) 1.69
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits. Antimicrob Agents Chemother (1983) 1.66
Beta-lactamase inhibitors from laboratory to clinic. Clin Microbiol Rev (1988) 1.52
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrob Agents Chemother (1984) 1.52
Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother (1982) 1.42
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 1.38
Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime. Antimicrob Agents Chemother (1981) 1.27
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid. Antimicrob Agents Chemother (1982) 1.25
Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother (1987) 1.19
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother (1985) 1.13
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1986) 1.08
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors. Antimicrob Agents Chemother (1980) 1.07
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections. Antimicrob Agents Chemother (1982) 1.05
Simple assay of beta-lactamase with agar medium containing a chromogenic cephalosporin, pyridinium-2-azo-p-dimethylaniline chromophore (PADAC). Antimicrob Agents Chemother (1988) 1.01
In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections. Antimicrob Agents Chemother (1987) 1.00
Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother (1986) 1.00
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother (1985) 0.99
Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi. Antimicrob Agents Chemother (1981) 0.99
Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children. Antimicrob Agents Chemother (1983) 0.97
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes. Antimicrob Agents Chemother (1991) 0.93
7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase. Antimicrob Agents Chemother (1982) 0.92
In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1989) 0.92
Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. Antimicrob Agents Chemother (1986) 0.89
Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy. Antimicrob Agents Chemother (1985) 0.88
beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate. Antimicrob Agents Chemother (1983) 0.88
In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays. Antimicrob Agents Chemother (2014) 0.86
Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila. Antimicrob Agents Chemother (1980) 0.86
Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother (1986) 0.85
Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations. Front Cell Infect Microbiol (2014) 0.85
Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy. Intensive Care Med (1994) 0.85
Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother (1983) 0.84
Induction of the Citrobacter freundii group I beta-lactamase in Escherichia coli is not dependent on entry of beta-lactam into the cytoplasm. Antimicrob Agents Chemother (1990) 0.82
Dithiolopyrrolone natural products: isolation, synthesis and biosynthesis. Mar Drugs (2013) 0.80
Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 0.80
Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 0.79
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid. J Clin Microbiol (1988) 0.79
Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice. Antimicrob Agents Chemother (1979) 0.79
BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2). Antimicrob Agents Chemother (2013) 0.78
Display of functional beta-lactamase inhibitory protein on the surface of M13 bacteriophage. Antimicrob Agents Chemother (1998) 0.76
Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria. Genitourin Med (1985) 0.75
A Flow Cytometric and Computational Approaches to Carbapenems Affinity to the Different Types of Carbapenemases. Front Microbiol (2016) 0.75
Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults. Antimicrob Agents Chemother (1985) 0.75
Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam. Antimicrob Agents Chemother (1982) 0.75
Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections. Antimicrob Agents Chemother (1983) 0.75
Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution? Pharmacogn Rev (2017) 0.75
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol (1973) 25.78
Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J (1965) 12.54
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother (1977) 11.58
Naturally-occurring beta-lactamase inhibitors with antibacterial activity. J Antibiot (Tokyo) (1976) 6.48
Purification and characterization of penicillinases from Salmonella typhimurium and Escherichia coli. Arch Biochem Biophys (1970) 5.39
Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12. Antimicrob Agents Chemother (1977) 4.45
Inhibition of beta-lactamases by beta-lactam antibiotics. Antimicrob Agents Chemother (1972) 3.72
Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins. Biochem J (1972) 3.57
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrob Agents Chemother (1978) 2.58
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. Chemotherapy (1975) 2.19
Letter: Two beta-lactamase inhibitors produced by a streptomyces. J Antibiot (Tokyo) (1973) 2.16
The demonstration and significance of synergism between -lactam antibiotics. J Med Microbiol (1971) 1.62
The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem (1965) 22.76
Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother (1974) 10.72
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1982) 10.08
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. Antimicrob Agents Chemother (1979) 10.01
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother (1974) 9.66
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 8.62
beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother (1978) 8.28
Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob Agents Chemother (1979) 7.65
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother (1978) 7.39
The new beta-lactamase-stable cephalosporins. Ann Intern Med (1982) 7.20
Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother (1978) 5.81
Purification and characterization of penicillinases from Salmonella typhimurium and Escherichia coli. Arch Biochem Biophys (1970) 5.39
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1983) 5.21
Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins. Antimicrob Agents Chemother (1978) 4.69
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother (1982) 4.45
Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother (1978) 4.28
Release of surface enzymes in Enterobacteriaceae by osmotic shock. J Bacteriol (1967) 4.05
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrob Agents Chemother (1986) 3.98
Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections. Ann Intern Med (1969) 3.62
On the surface localization of enzymes in E. coli. Biochem Biophys Res Commun (1964) 3.52
Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins. Antimicrob Agents Chemother (1972) 3.50
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1981) 3.50
In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 3.45
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin. Antimicrob Agents Chemother (1984) 3.40
In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother (1976) 3.35
In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1976) 3.25
In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 3.23
Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. Antimicrob Agents Chemother (1975) 3.17
Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1980) 3.14
Infective endocarditis--an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973. Medicine (Baltimore) (1978) 3.03
In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother (1983) 3.00
Comparative inhibition beta-lactamases by novel beta-lactam compounds. Antimicrob Agents Chemother (1979) 2.97
The surface localization of penicillinases in Escherichia coli and Salmonella typhimurium. Biochem Biophys Res Commun (1968) 2.76
The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime. J Antibiot (Tokyo) (1979) 2.67
Pharmacokinetics of cefotaxime. Antimicrob Agents Chemother (1979) 2.67
Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med (1971) 2.66
The 5'-nucleotidase of Escherichia coli. I. Purification and properties. J Biol Chem (1967) 2.59
Antibacterial activity of a monocyclic beta-lactam SQ 26,776. J Antimicrob Chemother (1981) 2.59
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA (1981) 2.55
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrob Agents Chemother (1988) 2.52
Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob Agents Chemother (1976) 2.42
Cefaclor: in vitro spectrum of activity and beta-lactamase stability. Antimicrob Agents Chemother (1978) 2.42
Testing the physician's knowledge of antibiotic use: Self-assessment and learning via videotape. N Engl J Med (1975) 2.35
Septicemia with non-typhoid salmonella. Medicine (Baltimore) (1974) 2.31
Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 2.26
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620. Antimicrob Agents Chemother (1986) 2.26
Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis (1996) 2.23
New macrolide antibiotics: azithromycin and clarithromycin. Ann Intern Med (1992) 2.22
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases. Am J Med (1985) 2.15
Bone and joint infections due to Salmonella. J Infect Dis (1978) 2.14
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet (1986) 2.14
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Am J Med (1987) 2.13
Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis (1975) 2.09
Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies. Diagn Microbiol Infect Dis (1991) 2.06
The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin Pharmacol Ther (1985) 1.99
The nephrotoxicity of antimicrobial agents (first of three parts). N Engl J Med (1977) 1.93
Rapid, reproducible enzyme immunoassay for gentamicin. J Clin Microbiol (1980) 1.92
In vitro studies of cephanone, a 3-heterocyclic-thiomethyl cephalosporin derivative. J Antibiot (Tokyo) (1973) 1.90
Oligonucleotide probe for detection and identification of Campylobacter pylori. J Clin Microbiol (1989) 1.90
Antibacterial activity and beta-lactamase stability of temocillin. Antimicrob Agents Chemother (1982) 1.87
A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot (Tokyo) (1978) 1.82
In vitro activity of sparfloxacin. Antimicrob Agents Chemother (1991) 1.79
The nephrotoxicity of antimicrobial agents (second of three parts). N Engl J Med (1977) 1.79
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother (1986) 1.79
In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. J Antimicrob Chemother (1985) 1.78
Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro. Appl Microbiol (1971) 1.77
Pharmacokinetics of ticarcillin in patients with abnormal renal function. J Infect Dis (1976) 1.77
Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis (1978) 1.75
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Antimicrob Agents Chemother (1986) 1.74
Gentamicin in 1978. Ann Intern Med (1978) 1.73
In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. Antimicrob Agents Chemother (1982) 1.70
In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin. Antimicrob Agents Chemother (1983) 1.69
Inactivation of beta-lactam antibiotics by Legionella pneumophila. Antimicrob Agents Chemother (1979) 1.69
Digoxin-inactivating bacteria: identification in human gut flora. Science (1983) 1.68
Kinetics of mezlocillin and carbenicillin. Clin Pharmacol Ther (1978) 1.65
Postsplenectomy infection. Surg Clin North Am (1981) 1.63
In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins. Antimicrob Agents Chemother (1978) 1.62
The release of ribonuclease into the medium when E. coli cells are converted to spheroplasts. Biochem Biophys Res Commun (1964) 1.62
Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods. Antimicrob Agents Chemother (1976) 1.62
In vitro activity and beta-lactamase stability of cefmenoxime. Antimicrob Agents Chemother (1982) 1.62